Get started
222

SL THERAPEUTICS

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

258540 chart


Full chart

Key stats


Market capitalization
‪9.44 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−913.34 M‬ KRW
Revenue (FY)
‪438.47 M‬ KRW
Shares float
—
Beta (1Y)
−0.90

Employees


Employees (FY)
6
Change (1Y)
0
Revenue / Employee (1Y)
‪56.12 K‬ KRW
Net income / Employee (1Y)
‪−116.91 K‬ KRW

About SL THERAPEUTICS


Sector
Health Technology
Industry
Medical Specialties
Headquarters
Seoul
Website
stemlab.co.kr
Founded
2011
ISIN
KR7258540004
FIGI
BBG00FF723H7
SL Therapeutics, Inc. engages in the development of therapeutic solutions to treat diseases. Its products include stem cell treatment, bone mineral density measuring equipment, magnetic resonance imaging equipment, cosmetics, and others. The company was founded on July 8, 2011 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 258540 is 883 KRW — it has increased by 4.12% in the past 24 hours. Watch SL THERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SL THERAPEUTICS stocks are traded under the ticker 258540.
258540 stock has risen by 23.25% compared to the previous week, the month change is a 12.05% rise, over the last year SL THERAPEUTICS has showed a 20.79% increase.
258540 reached its all-time high on Apr 25, 2019 with the price of 10,933 KRW, and its all-time low was 376 KRW and was reached on Oct 26, 2023. View more price dynamics on 258540 chart.
See other stocks reaching their highest and lowest prices.
258540 stock is 17.25% volatile and has beta coefficient of −0.90. Track SL THERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is SL THERAPEUTICS there?
Today SL THERAPEUTICS has the market capitalization of ‪9.26 B‬, it has increased by 11.28% over the last week.
Yes, you can track SL THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
No, 258540 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 6.00 employees. See our rating of the largest employees — is SL THERAPEUTICS on this list?
Like other stocks, 258540 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SL THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SL THERAPEUTICS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SL THERAPEUTICS stock shows the sell signal. See more of SL THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.